Mri-guided active surveillance in prostate cancer: not yet ready for practice

Multiparametric MRI enables early detection of progression and reclassification in patients with low-risk prostate cancer on active surveillance and offers the potential to reduce

unnecessary biopsies. However, the reliability and reproducibility of MRI-directed surveillance during follow-up is unclear. A recent study highlights the potential and current shortcomings

of this approach. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution

Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $29.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 12

print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be

subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support

REFERENCES * Bokhorst, L. P. et al. A decade of active surveillance in the PRIAS Study: an update and evaluation of the criteria used to recommend a switch to active treatment. _Eur. Urol._

70, 954–960 (2016). Article  Google Scholar  * Lantz, A. et al. Expanding active surveillance inclusion criteria: a novel nomogram including preoperative clinical parameters and magnetic

resonance imaging findings. _Eur. Urol. Oncol._ 357, 1–8 (2020). Google Scholar  * Fujihara, A. et al. Multiparametric magnetic resonance imaging facilitates reclassification during active

surveillance for prostate cancer. _BJU Int._ https://doi.org/10.1111/bju.15272 (2020). Article  PubMed  Google Scholar  * Moore, C. M. et al. Reporting magnetic resonance imaging in men on

active surveillance for prostate cancer: the PRECISE recommendations-a report of a European School of Oncology task force. _Eur. Urol._ 71, 648–655 (2017). Article  Google Scholar  *

Giganti, F. et al. Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort. _Eur. Radiol._

https://doi.org/10.1007/s00330-020-07256-z (2020). Article  PubMed  PubMed Central  Google Scholar  * Klotz, L. et al. Randomized study of systematic biopsy versus magnetic resonance imaging

and targeted and systematic biopsy in men on active surveillance (ASIST): 2-year postbiopsy follow-up. _Eur. Urol._ 77, 311–317 (2020). Article  Google Scholar  * Ploussard, G. et al. Added

value of concomitant systematic and fusion targeted biopsies for grade group prediction based on radical prostatectomy final pathology on positive magnetic resonance imaging. _J. Urol._

202, 1182–1187 (2019). Article  Google Scholar  * Ploussard, G. et al. Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study.

_World J. Urol._ 38, 1735–1740 (2020). Article  Google Scholar  * Stavrinides, V. et al. Five-year outcomes of magnetic resonance imaging-based active surveillance for prostate cancer: a

large cohort study. _Eur. Urol._ 78, 443–451 (2020). Article  CAS  Google Scholar  * Chesnut, G. T. et al. Role of changes in magnetic resonance imaging or clinical stage in evaluation of

disease progression for men with prostate cancer on active surveillance. _Eur. Urol._ 77, 501–507 (2020). Article  Google Scholar  Download references AUTHOR INFORMATION AUTHORS AND

AFFILIATIONS * Department of Urology, La Croix du Sud Hospital, Quint Fonsegrives, France Guillaume Ploussard * Department of Radiology, Pitié-Salpétrière Hospital, Paris-Sorbonne

University, Paris, France Raphaële Renard-Penna Authors * Guillaume Ploussard View author publications You can also search for this author inPubMed Google Scholar * Raphaële Renard-Penna

View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Guillaume Ploussard. ETHICS DECLARATIONS COMPETING INTERESTS The

authors declare no competing interests ADDITIONAL INFORMATION RELATED LINKS EAU PROSTATE CANCER TREATMENT GUIDELINES: https://uroweb.org/guideline/prostate-cancer/?type=summary-of-changes

RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Ploussard, G., Renard-Penna, R. MRI-guided active surveillance in prostate cancer: not yet ready for

practice. _Nat Rev Urol_ 18, 77–78 (2021). https://doi.org/10.1038/s41585-020-00416-2 Download citation * Published: 11 December 2020 * Issue Date: February 2021 * DOI:

https://doi.org/10.1038/s41585-020-00416-2 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not

currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative